首页> 外文会议>International Advanced Research Workshop on In Silico Oncology and Cancer Investigation >In Silico Oncology - Leading the Way at the Dawning of In Silico Medicine
【24h】

In Silico Oncology - Leading the Way at the Dawning of In Silico Medicine

机译:在Silico肿瘤学 - 在Silico Medicine的Dawning领先

获取原文

摘要

Cancer is a natural phenomenon and consequently is amenable to mathematical and computational description. Clinically driven complex multi-scale cancer models are capable of producing realistic spatio-temporal and patient-specific simulations of commonly-used clinical interventions such as radio-chemotherapy. Clinical data-processing procedures and computer technologies play an important role in this context. Following clinical adaptation and validation within the framework of clinico-genomic trials, models are expected to advance the prospect of individualized treatment optimization, this being the long term goal of the emergent scientific, technological and medical discipline of in silico oncology.
机译:癌症是一种自然现象,因此可用于数学和计算描述。临床驱动的复杂的多尺度癌症模型能够生产现实的时空和患者特异性模拟常用的临床干预,例如无线电化疗。临床数据处理程序和计算机技术在这种背景下发挥着重要作用。在临床 - 基因组试验框架内进行临床适应和验证,预计模型将推动个性化治疗优化的前景,这是Silico肿瘤学的紧急科学,技术和医学学科的长期目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号